Comerica Bank’s VanEck Biotech ETF BBH Stock Holding History

Comerica Bank’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$128K	Hold	675	–	–	﹤0.01%	2528
2025 Q3	$112K	Hold	675	–	–	﹤0.01%	2560
2025 Q2	$103K	Hold	675	–	–	﹤0.01%	2585
2025 Q1	$106K	Sell	675 -146	-18%	-$23.7K	﹤0.01%	2554
2024 Q4	$129K	Sell	821 -99	-11%	-$16.7K	﹤0.01%	2481
2024 Q3	$163K	Hold	920	–	–	﹤0.01%	2376
2024 Q2	$155K	Hold	920	–	–	﹤0.01%	2369
2024 Q1	$153K	Sell	920 -20	-2%	-$3.31K	﹤0.01%	2404
2023 Q4	$155K	Buy	940 +19	+2%	+$2.92K	﹤0.01%	2342
2023 Q3	$143K	Buy	+921	New	+$147K	﹤0.01%	2347

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

Comerica Bank's BBH Position: Q4 2025 in Review

Comerica Bank held its VanEck Biotech ETF (BBH) position steady in Q4 2025 at 675 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #2528.

Comerica Bank first reported a position in BBH in Q3 2023 and has held it in 10 quarters since. The position peaked at $163K in Q3 2024. 111 funds tracked by Wall St. Rank hold BBH as of Q4 2025.

Comerica Bank held 675 shares of VanEck Biotech ETF worth $128K as of Q4 2025.
Comerica Bank left its VanEck Biotech ETF share count unchanged in Q4 2025.
VanEck Biotech ETF made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2528 holding.
Comerica Bank first reported a position in VanEck Biotech ETF in Q3 2023 and has held it in 10 quarters since.
Comerica Bank's VanEck Biotech ETF position peaked at $163K in Q3 2024.
111 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.